Biotech Analyst Kaczor, along with Medical Director of Insulet, Dr. Trang Ly, discuss Type 2 Diabetes and GLP-1 on an Analyst/Industry conference call to be held on September 8 at 11 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PODD:
- William Blair biotech analyst to hold an analyst/industry conference call
- Insulet price target lowered to $215 from $270 at UBS
- Early notable gainers among liquid option names on August 30th
- Insider Trading: Insulet (NASDAQ:PODD) Gains as Top Executive Makes Share Purchase
- Insulet CEO buys $1.0M in common stock